Global RNA Vaccines Market Insights, Forecast to 2025

Publisher Name :
Date: 08-Mar-2019
No. of pages: 113
Inquire Before Buying

RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.

RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.

The global RNA Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the RNA Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of RNA Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of RNA Vaccines in these regions.

This research report categorizes the global RNA Vaccines market by top players/brands, region, type and end user. This report also studies the global RNA Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Moderna Therapeutics

- CureVac

- Translate Bio

- BioNTech

- Sangamo Therapeutics

- Argos Therapeutics

- In-Cell-Art

- eTheRNA

- Ethris

- Tiba Biotechnology

Market size by Product

- Individualized Cancer Treatment MRNA Vaccine

- Infectious Disease Treatment MRNA Vaccine

- Infection Prevention MRNA Vaccine

Market size by End User

- Infectious Disease

- Cancer

- Other

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global RNA Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of RNA Vaccines market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global RNA Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of RNA Vaccines submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of RNA Vaccines are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of RNA Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global RNA Vaccines Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 RNA Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global RNA Vaccines Market Size Growth Rate by Product
1.4.2 Individualized Cancer Treatment MRNA Vaccine
1.4.3 Infectious Disease Treatment MRNA Vaccine
1.4.4 Infection Prevention MRNA Vaccine
1.5 Market by End User
1.5.1 Global RNA Vaccines Market Size Growth Rate by End User
1.5.2 Infectious Disease
1.5.3 Cancer
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global RNA Vaccines Market Size
2.1.1 Global RNA Vaccines Revenue 2014-2025
2.1.2 Global RNA Vaccines Sales 2014-2025
2.2 RNA Vaccines Growth Rate by Regions
2.2.1 Global RNA Vaccines Sales by Regions
2.2.2 Global RNA Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 RNA Vaccines Sales by Manufacturers
3.1.1 RNA Vaccines Sales by Manufacturers
3.1.2 RNA Vaccines Sales Market Share by Manufacturers
3.1.3 Global RNA Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 RNA Vaccines Revenue by Manufacturers
3.2.1 RNA Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 RNA Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 RNA Vaccines Price by Manufacturers
3.4 RNA Vaccines Manufacturing Base Distribution, Product Types
3.4.1 RNA Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers RNA Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into RNA Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global RNA Vaccines Sales by Product
4.2 Global RNA Vaccines Revenue by Product
4.3 RNA Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global RNA Vaccines Breakdown Data by End User
6 North America
6.1 North America RNA Vaccines by Countries
6.1.1 North America RNA Vaccines Sales by Countries
6.1.2 North America RNA Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America RNA Vaccines by Product
6.3 North America RNA Vaccines by End User
7 Europe
7.1 Europe RNA Vaccines by Countries
7.1.1 Europe RNA Vaccines Sales by Countries
7.1.2 Europe RNA Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe RNA Vaccines by Product
7.3 Europe RNA Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific RNA Vaccines by Countries
8.1.1 Asia Pacific RNA Vaccines Sales by Countries
8.1.2 Asia Pacific RNA Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific RNA Vaccines by Product
8.3 Asia Pacific RNA Vaccines by End User
9 Central & South America
9.1 Central & South America RNA Vaccines by Countries
9.1.1 Central & South America RNA Vaccines Sales by Countries
9.1.2 Central & South America RNA Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America RNA Vaccines by Product
9.3 Central & South America RNA Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa RNA Vaccines by Countries
10.1.1 Middle East and Africa RNA Vaccines Sales by Countries
10.1.2 Middle East and Africa RNA Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa RNA Vaccines by Product
10.3 Middle East and Africa RNA Vaccines by End User
11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Company Business Overview
11.1.3 Moderna Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Moderna Therapeutics RNA Vaccines Products Offered
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 Company Business Overview
11.2.3 CureVac RNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 CureVac RNA Vaccines Products Offered
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Company Business Overview
11.3.3 Translate Bio RNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Translate Bio RNA Vaccines Products Offered
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 Company Business Overview
11.4.3 BioNTech RNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BioNTech RNA Vaccines Products Offered
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 Sangamo Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sangamo Therapeutics RNA Vaccines Products Offered
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Company Business Overview
11.6.3 Argos Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Argos Therapeutics RNA Vaccines Products Offered
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 Company Business Overview
11.7.3 In-Cell-Art RNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 In-Cell-Art RNA Vaccines Products Offered
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 Company Business Overview
11.8.3 eTheRNA RNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 eTheRNA RNA Vaccines Products Offered
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Company Business Overview
11.9.3 Ethris RNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Ethris RNA Vaccines Products Offered
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Company Business Overview
11.10.3 Tiba Biotechnology RNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Tiba Biotechnology RNA Vaccines Products Offered
11.10.5 Tiba Biotechnology Recent Development
12 Future Forecast
12.1 RNA Vaccines Market Forecast by Regions
12.1.1 Global RNA Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global RNA Vaccines Revenue Forecast by Regions 2019-2025
12.2 RNA Vaccines Market Forecast by Product
12.2.1 Global RNA Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global RNA Vaccines Revenue Forecast by Product 2019-2025
12.3 RNA Vaccines Market Forecast by End User
12.4 North America RNA Vaccines Forecast
12.5 Europe RNA Vaccines Forecast
12.6 Asia Pacific RNA Vaccines Forecast
12.7 Central & South America RNA Vaccines Forecast
12.8 Middle East and Africa RNA Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 RNA Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure RNA Vaccines Product Picture
Table RNA Vaccines Market Segments
Table Key Manufacturers RNA Vaccines Covered
Table Global RNA Vaccines Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global RNA Vaccines Sales Market Share by Product 2014-2025
Figure Individualized Cancer Treatment MRNA Vaccine Product Picture
Table Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine
Figure Infectious Disease Treatment MRNA Vaccine Product Picture
Table Major Manufacturers of Infectious Disease Treatment MRNA Vaccine
Figure Infection Prevention MRNA Vaccine Product Picture
Table Major Manufacturers of Infection Prevention MRNA Vaccine
Table Global RNA Vaccines Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Infectious Disease
Figure Cancer
Figure Other
Figure RNA Vaccines Report Years Considered
Figure Global RNA Vaccines Market Size 2014-2025 (Million US$)
Figure Global RNA Vaccines Sales 2014-2025 (K Doses)
Table Global RNA Vaccines Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global RNA Vaccines Sales by Regions 2014-2019 (K Doses)
Table Global RNA Vaccines Sales Market Share by Regions 2014-2019
Figure Global RNA Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global RNA Vaccines Sales Market Share by Regions
Table Global RNA Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global RNA Vaccines Revenue Market Share by Regions 2014-2019
Figure Global RNA Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global RNA Vaccines Revenue Market Share by Regions
Table Global RNA Vaccines Sales by Manufacturers (2014-2019) (K Doses)
Table Global RNA Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global RNA Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table RNA Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table RNA Vaccines Revenue Share by Manufacturers (2014-2019)
Figure RNA Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers RNA Vaccines Price (2014-2019) (USD/Dose)
Table RNA Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers RNA Vaccines Product Type
Table Date of International Manufacturers Enter into RNA Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global RNA Vaccines Sales by Product (2014-2019) (K Doses)
Table Global RNA Vaccines Sales Share by Product (2014-2019)
Figure Global RNA Vaccines Sales Market Share by Product (2014-2019)
Figure Global RNA Vaccines Sales Market Share by Product in 2018
Table Global RNA Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global RNA Vaccines Revenue Share by Product (2014-2019)
Figure Global RNA Vaccines Revenue Market Share by Product (2014-2019)
Figure Global RNA Vaccines Revenue Market Share by Product in 2018
Table RNA Vaccines Price by Product 2014-2019 (USD/Dose)
Table Global RNA Vaccines Sales by End User (2014-2019) (K Doses)
Table Global RNA Vaccines Sales Share by End User (2014-2019)
Figure Global Sales RNA Vaccines Market Share by End User (2014-2019)
Figure Global Sales RNA Vaccines Market Share by End User in 2018
Figure North America RNA Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure North America RNA Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America RNA Vaccines Sales by Countries (2014-2019) (K Doses)
Table North America RNA Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America RNA Vaccines Sales Market Share by Countries
Table North America RNA Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America RNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America RNA Vaccines Revenue Market Share by Countries
Figure United States RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure United States RNA Vaccines Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Canada RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America RNA Vaccines Sales by Product (2014-2019) (K Doses)
Table North America RNA Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America RNA Vaccines Market Share by Product
Table North America RNA Vaccines Sales by End User (2014-2019) (K Doses)
Table North America RNA Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America RNA Vaccines Market Share by End User
Figure Europe RNA Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Europe RNA Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe RNA Vaccines Sales by Countries (2014-2019) (K Doses)
Table Europe RNA Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe RNA Vaccines Sales Market Share by Countries
Table Europe RNA Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe RNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe RNA Vaccines Revenue Market Share by Countries
Figure Germany RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Germany RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure France RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure UK RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Italy RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Russia RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe RNA Vaccines Sales by Product (2014-2019) (K Doses)
Table Europe RNA Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe RNA Vaccines Market Share by Product
Table Europe RNA Vaccines Sales by End User (2014-2019) (K Doses)
Table Europe RNA Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe RNA Vaccines Market Share by End User
Figure Asia Pacific RNA Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific RNA Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific RNA Vaccines Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific RNA Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific RNA Vaccines Sales Market Share by Countries
Table Asia Pacific RNA Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific RNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific RNA Vaccines Revenue Market Share by Countries
Figure China RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure China RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Japan RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Korea RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure India RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Australia RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific RNA Vaccines Sales by Product (2014-2019) (K Doses)
Table Asia Pacific RNA Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific RNA Vaccines Market Share by Product
Table Asia Pacific RNA Vaccines Sales by End User (2014-2019) (K Doses)
Table Asia Pacific RNA Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific RNA Vaccines Market Share by End User
Figure Central & South America RNA Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America RNA Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America RNA Vaccines Sales by Countries (2014-2019) (K Doses)
Table Central & South America RNA Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America RNA Vaccines Sales Market Share by Countries
Table Central & South America RNA Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America RNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America RNA Vaccines Revenue Market Share by Countries
Figure Brazil RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America RNA Vaccines Sales by Product (2014-2019) (K Doses)
Table Central & South America RNA Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America RNA Vaccines Market Share by Product
Table Central & South America RNA Vaccines Sales by End User (2014-2019) (K Doses)
Table Central & South America RNA Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America RNA Vaccines Market Share by End User
Figure Middle East and Africa RNA Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa RNA Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa RNA Vaccines Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa RNA Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa RNA Vaccines Sales Market Share by Countries
Table Middle East and Africa RNA Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa RNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa RNA Vaccines Revenue Market Share by Countries
Figure GCC Countries RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa RNA Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa RNA Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa RNA Vaccines Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa RNA Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa RNA Vaccines Market Share by Product
Table Middle East and Africa RNA Vaccines Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa RNA Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa RNA Vaccines Market Share by End User
Table Moderna Therapeutics Company Details
Table Moderna Therapeutics RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Moderna Therapeutics Recent Development
Table CureVac Company Details
Table CureVac RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table CureVac Recent Development
Table Translate Bio Company Details
Table Translate Bio RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Translate Bio Recent Development
Table BioNTech Company Details
Table BioNTech RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table BioNTech Recent Development
Table Sangamo Therapeutics Company Details
Table Sangamo Therapeutics RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sangamo Therapeutics Recent Development
Table Argos Therapeutics Company Details
Table Argos Therapeutics RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Argos Therapeutics Recent Development
Table In-Cell-Art Company Details
Table In-Cell-Art RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table In-Cell-Art Recent Development
Table eTheRNA Company Details
Table eTheRNA RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table eTheRNA Recent Development
Table Ethris Company Details
Table Ethris RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Ethris Recent Development
Table Tiba Biotechnology Company Details
Table Tiba Biotechnology RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Tiba Biotechnology Recent Development
Table Global RNA Vaccines Sales Forecast by Regions 2019-2025 (K Doses)
Table Global RNA Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global RNA Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global RNA Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global RNA Vaccines Sales Forecast by Product 2019-2025 (K Doses)
Table Global RNA Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global RNA Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global RNA Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global RNA Vaccines Sales Forecast by End User 2019-2025 (K Doses)
Table Global RNA Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America RNA Vaccines Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America RNA Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe RNA Vaccines Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe RNA Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific RNA Vaccines Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific RNA Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America RNA Vaccines Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America RNA Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa RNA Vaccines Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa RNA Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table RNA Vaccines Value Chain
Table RNA Vaccines Customers List
Table RNA Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antihemorrhagic Agent Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 102
    Market Overview The global Antihemorrhagic Agent market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antihemorrhagic Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales an......
  • Global PVA Embolization Particles Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 102
    Market Overview The global PVA Embolization Particles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The PVA Embolization Particles market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape......
  • Global Bisoprolol Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 100
    Market Overview The global Bisoprolol market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bisoprolol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of dome......
  • Global Sotalol Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 105
    Market Overview The global Sotalol market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sotalol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic a......
  • Global Amiodarone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 102
    Market Overview The global Amiodarone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Amiodarone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of dome......
  • Global Physiological Seawater Nasal Spray Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 102
    Market Overview The global Physiological Seawater Nasal Spray market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Physiological Seawater Nasal Spray market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, compe......
  • Global Disintegrants Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 109
    Market Overview The global Disintegrants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Disintegrants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact o......
  • Global Enteric Coating Market Research Report 2020
    Published: 25-Feb-2020        Price: US 2900 Onwards        Pages: 91
    This report focuses on Enteric Coating volume and value at global level, regional level and company level. From a global perspective, this report represents overall Enteric Coating market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.......
  • Global Nattokinase Supplements Market Research Report 2020
    Published: 25-Feb-2020        Price: US 2900 Onwards        Pages: 121
    This report focuses on Nattokinase Supplements volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nattokinase Supplements market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs